Pacira BioSciences
PCRX
PCRX
260 hedge funds and large institutions have $3.01B invested in Pacira BioSciences in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 105 increasing their positions, 84 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 257 → 260 (+3)
4% more capital invested
Capital invested by funds: $2.9B → $3.01B (+$115M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
260
Holding in Top 10
3
Calls
$10.1M
Puts
$8.96M
Top Buyers
| 1 | +$35M | |
| 2 | +$26.2M | |
| 3 | +$18.4M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$17.5M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$13.9M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$9.28M | |
| 3 | -$8.87M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.42M |
| 5 |
Man Group
London,
United Kingdom
|
-$7.36M |